Breaking News Instant updates and real-time market news.

BHC

Bausch Health

$27.14

1.59 (6.22%)

11:01
11/06/18
11/06
11:01
11/06/18
11:01

Bausch Health continues to underspend on R&D to fuel upside, says Wells Fargo

Wells Fargo analyst David Maris said Bausch Health has been underspending on R&D to help fuel better than expected results and Q3 "was not different" in that respect. Of note, Bausch also announced it is starting an ongoing efficiency initiative, which would proactively reduce channel inventory in Q4. Maris continues to see Bausch Health shares carrying too much risk to recommend and keeps an Underperform rating on the stock.

  • 06

    Nov

  • 27

    Nov

  • 15

    Feb

  • 25

    Feb

BHC Bausch Health
$27.14

1.59 (6.22%)

10/08/18
WELS
10/08/18
NO CHANGE
WELS
Underperform
Bausch Health approval of Bryhali largely expected, says Wells Fargo
Bausch Health announced this morning that final approval of Bryhali Lotion for the treatment of plaque psoriasis in adults is pending the expiration of exclusivity for a related product, which is expected to occur in early November, Wells Fargo analyst David Maris tells investors in a research note. The analyst reiterates his belief that the market largely expected Bausch would receive approval for Bryhali since the active ingredient is already available as a generic and other similar products are already approved using this active ingredient. While unaware the approval would be held up based on the exclusivity of another product, Maris does not consider the one or two month delay as significant. He currently models Bryhali sales of $17M in 2019, and peak sales of approximately $75M. Maris keeps an Underperform rating on shares of Bausch Health, which are trading up 4% to $27.37 in early trading.
10/15/18
MZHO
10/15/18
NO CHANGE
Target $35
MZHO
Buy
Bausch Health Q3 consensus estimates have upside, says Mizuho
Mizuho analyst Irina Koffler sees potential upside to Bausch Health's Q3 consensus estimates and she reiterates a Buy rating on the shares with a $35 price target. The analyst expects "strong" Xifaxan growth to persist into 2019 and believes that the Alcon spin valuation may provide a positive read-through to Bausch's B+L segment valuation.
11/05/18
MSCO
11/05/18
UPGRADE
MSCO
Overweight
Bausch Health upgraded to Overweight from Equal Weight at Morgan Stanley
11/05/18
11/05/18
UPGRADE
Target $32

Overweight
Bausch Health upgraded to Overweight on improving growth at Morgan Stanley
As previously reported, Morgan Stanley analyst David Risinger upgraded Bausch Health to Overweight from Equal Weight, as he expects improved growth in 2020, a mix shift toward new products and gradual debt paydown to drive the stock's multiple higher. He continues to project Q3 EBITDA of $850M, 5% above consensus, and sees the upcoming quarterly report as a potential catalyst to drive the stock up, Risinger added. He set a $32 price target on Bausch Health shares.

TODAY'S FREE FLY STORIES

PLXP

PLx Pharma

$5.11

-0.11 (-2.11%)

07:27
02/19/19
02/19
07:27
02/19/19
07:27
Conference/Events
PLx Pharma to host special shareholder meeting »

Special shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

NBRV

Nabriva Therapeutics

$2.08

0.045 (2.22%)

07:27
02/19/19
02/19
07:27
02/19/19
07:27
Hot Stocks
Nabriva Therapeutics announces FDA acceptance of lefamulin NDAs »

Nabriva Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

WORX

SCWorx

$5.74

-0.07 (-1.20%)

07:27
02/19/19
02/19
07:27
02/19/19
07:27
Hot Stocks
SCWorx announces new customer service agreement »

SCWorx has expanded its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARNC

Arconic

$17.56

0.07 (0.40%)

, JPM

JPMorgan

$105.56

3.14 (3.07%)

07:25
02/19/19
02/19
07:25
02/19/19
07:25
Hot Stocks
Arconic announces $700M accelerated share repurchase agreement »

Arconic (ARNC) announced…

ARNC

Arconic

$17.56

0.07 (0.40%)

JPM

JPMorgan

$105.56

3.14 (3.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

ICPT

Intercept

$110.77

-0.42 (-0.38%)

07:24
02/19/19
02/19
07:24
02/19/19
07:24
Hot Stocks
Intercept intends to file for OCA regulatory approval in U.S., Europe in 2H19 »

"We are thrilled to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    May

CNMD

Conmed

$71.94

0.73 (1.03%)

07:24
02/19/19
02/19
07:24
02/19/19
07:24
Upgrade
Conmed rating change  »

Conmed reinstated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

  • 18

    May

ACB

Aurora Cannabis

$7.04

-0.05 (-0.71%)

, TLRY

Tilray

$76.46

-0.2 (-0.26%)

07:23
02/19/19
02/19
07:23
02/19/19
07:23
Recommendations
Aurora Cannabis, Tilray, CV Sciences, Cronos Group, General Cannabis, CannTrust Holdings, Aphria, MediPharm Labs, Canopy Growth, India Globalization Capital analyst commentary  »

Moody's price target…

ACB

Aurora Cannabis

$7.04

-0.05 (-0.71%)

TLRY

Tilray

$76.46

-0.2 (-0.26%)

CVSI

CV Sciences

$0.00

(0.00%)

CRON

Cronos Group

$21.28

0.46 (2.21%)

CANN

General Cannabis

$0.00

(0.00%)

CNTTF

CannTrust Holdings

$0.00

(0.00%)

APHA

Aphria

$9.58

0.49 (5.39%)

MLCPF

MediPharm Labs

$0.00

(0.00%)

CGC

Canopy Growth

$47.54

1.49 (3.24%)

IGC

India Globalization Capital

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 21

    Feb

ICPT

Intercept

$110.77

-0.42 (-0.38%)

07:22
02/19/19
02/19
07:22
02/19/19
07:22
Hot Stocks
Breaking Hot Stocks news story on Intercept »

Intercept jumps 36% after…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    May

ICPT

Intercept

$110.77

-0.42 (-0.38%)

07:22
02/19/19
02/19
07:22
02/19/19
07:22
Hot Stocks
Intercept announces results from Phase 3 REGENERATE study »

Intercept announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    May

NBLX

Noble Midstream

$32.09

-0.04 (-0.12%)

07:21
02/19/19
02/19
07:21
02/19/19
07:21
Earnings
Noble Midstream reports Q4 EPS $1.00, consensus $1.03 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

FCAU

Fiat Chrysler

$14.75

0.09 (0.61%)

07:21
02/19/19
02/19
07:21
02/19/19
07:21
Downgrade
Fiat Chrysler rating change  »

Fiat Chrysler downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XPO

XPO Logistics

$52.01

-7.535 (-12.65%)

, UPS

UPS

$110.89

-0.91 (-0.81%)

07:20
02/19/19
02/19
07:20
02/19/19
07:20
Downgrade
XPO Logistics, UPS, FedEx, C.H. Robinson, Amazon.com rating change  »

Morgan Stanley downgrades…

XPO

XPO Logistics

$52.01

-7.535 (-12.65%)

UPS

UPS

$110.89

-0.91 (-0.81%)

FDX

FedEx

$179.20

-4.74 (-2.58%)

CHRW

C.H. Robinson

$91.43

0.74 (0.82%)

AMZN

Amazon.com

$1,608.88

-13.47 (-0.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 03

    Mar

  • 18

    Mar

  • 19

    Mar

  • 01

    Apr

  • 02

    Apr

CTB

Cooper Tire

$34.04

0.66 (1.98%)

07:19
02/19/19
02/19
07:19
02/19/19
07:19
Hot Stocks
Cooper Tire sees modest unit volume growth compared to 2018 »

Sees improving operating…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Mar

  • 14

    May

  • 15

    May

  • 16

    May

CTB

Cooper Tire

$34.04

0.66 (1.98%)

07:18
02/19/19
02/19
07:18
02/19/19
07:18
Hot Stocks
Cooper Tire sees Q1 operating profit margin lower than Q1 »

Management expects Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Mar

  • 14

    May

  • 15

    May

  • 16

    May

XPO

XPO Logistics

$52.01

-7.535 (-12.65%)

07:17
02/19/19
02/19
07:17
02/19/19
07:17
Recommendations
XPO Logistics analyst commentary  »

Deutsche puts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

OPTN

Optinose

$7.40

0.23 (3.21%)

07:17
02/19/19
02/19
07:17
02/19/19
07:17
Hot Stocks
Optinose announces four additional Xhance patents from USPTO »

Optinose announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SXT

Sensient

$62.77

0.19 (0.30%)

07:15
02/19/19
02/19
07:15
02/19/19
07:15
Downgrade
Sensient rating change  »

Sensient downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

CRSP

Crispr Therapeutics

$31.62

0.65 (2.10%)

07:15
02/19/19
02/19
07:15
02/19/19
07:15
Hot Stocks
Crispr Therapeutics, StrideBio announce expanded strategic collaboration »

Crispr Therapeutics and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CEVA

Ceva

$28.91

1.23 (4.44%)

07:14
02/19/19
02/19
07:14
02/19/19
07:14
Hot Stocks
Ceva announces collaboration to add C-V2X Rel. 14/15 support to the CEVA-XC DSP »

CEVA announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLUG

Plug Power

$1.62

-0.045 (-2.70%)

07:14
02/19/19
02/19
07:14
02/19/19
07:14
Hot Stocks
Plug Power begins production of next gen class 1 material handling equipment »

Plug Power announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTB

Cooper Tire

$34.04

0.66 (1.98%)

07:13
02/19/19
02/19
07:13
02/19/19
07:13
Earnings
Cooper Tire reports Q4 EPS ex-items 66c, consensus 58c »

Reports Q4 revenue $770M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Mar

  • 14

    May

  • 15

    May

  • 16

    May

ARAV

Aravive

$4.95

0.2 (4.21%)

07:13
02/19/19
02/19
07:13
02/19/19
07:13
Hot Stocks
Aravive receives additional $2.6M disbursement from CPRIT for AVB-S6-500 »

Aravive announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CASI

Casi Pharmaceuticals

$3.59

0.07 (1.99%)

, SPPI

Spectrum

$11.71

0.03 (0.26%)

07:13
02/19/19
02/19
07:13
02/19/19
07:13
Hot Stocks
Casi Pharmaceuticals: NMPA approves CTA for trial of ZEVALIN »

CASI Pharmaceuticals…

CASI

Casi Pharmaceuticals

$3.59

0.07 (1.99%)

SPPI

Spectrum

$11.71

0.03 (0.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 20

    Feb

PHIIK

PHI Inc

$3.10

0.01 (0.32%)

07:12
02/19/19
02/19
07:12
02/19/19
07:12
Hot Stocks
PHI Inc shareholder Stabosz calls on company to address Debtwire story »

One of PHI, Inc.'s…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XPO

XPO Logistics

$52.01

-7.535 (-12.65%)

07:12
02/19/19
02/19
07:12
02/19/19
07:12
Recommendations
XPO Logistics analyst commentary  »

XPO Logistics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.